SpaceX-xAI Merger<\/p>\n
The exodus follows the all-stock acquisition that merged Elon Musk\u2019s xAI into his rocket manufacturing firm SpaceX, creating one of the world\u2019s most valuable private companies.<\/p>\n
The Information noted that leaders of teams working on coding, world models, and Grok voice left the company earlier this month. The exits have effectively brought down the number of researchers at xAI from 200 as of late last year, the report said, while noting the culture of extreme overwork was a factor that likely contributed to the exits.<\/p>\n
Who Is Hiring?<\/p>\n
Meta and Thinking Machines Lab have been among the most active recruiters of the former xAI talent, offering substantial compensation packages, as per the report. Several alumni have also joined other frontier AI labs or launched their own ventures.<\/p>\n
According to the report, Meta has hired at least 11 researchers and engineers from xAI since February, while Thinking Machines has roped in at least seven people over the same timeframe. Claude-parent Anthropic, meanwhile, hired at least two former xAI employees this year.<\/p>\n
Musk\u2019s Vision For SpaceX<\/p>\n
Earlier this month, Musk said that xAI will be dissolved as a standalone company and fully integrated into SpaceX, rebranding its AI efforts as SpaceXAI.<\/p>\n
The renaming comes as SpaceX prepares for one of the largest initial public offerings in history. The company is targeting a mid-2026 IPO \u2014 possibly as early as June \u2014 with valuations discussed in the $1.75 trillion to $2 trillion range.<\/p>\n
How Do Retail Traders Feel?<\/p>\n
On Stocktwits, retail sentiment around SPACEX<\/a> trended within the \u2018bullish\u2019 territory over the past 24 hours, while message volume stayed at \u2018high\u2019 levels.<\/p>\n Meanwhile, sentiment around META stayed within the \u2018bullish\u2019 territory over the past 24 hours while message volume stayed at \u2018normal\u2019 levels.<\/p>\n META stock<\/a> has fallen 6% over the past 12 months.\u00a0<\/p>\n Read More: AARD Stock Plummets After Hours As Cardiac Safety Concerns Trigger FDA Hold On Late-stage Program<\/a><\/p>\n For updates and corrections, email newsroom[at]stocktwits[dot]com.<\/p>\n
![\"Follow](\"https:\/\/chunks-prd.stocktwits-cdn.com\/_next\/static\/media\/google-news-icon.d9c2bfd1.svg\"\/){kind=icon}
<\/a><\/p>\n